Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen prophylaxis for bleeding during pelvic surgery
IRCT20200109046064N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in perioperative bleeding comparing Fibrinogen with Placebo (2 arms). Primary endpoint: Plasma fibrinogen. Started Feb 2020; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on IRCT20200109046064N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200109046064N1.